Salomon & Ludwin’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24K Sell
104
-88
-46% -$24.3K ﹤0.01% 1005
2026
Q1
$58.6K Hold
192
0.01% 410
2025
Q4
$52.8K Buy
192
+76
+66% +$20.7K ﹤0.01% 394
2025
Q3
$30.7K Buy
116
+51
+78% +$13.9K ﹤0.01% 569
2025
Q2
$17.9K Buy
+65
New +$17.7K ﹤0.01% 399
2024
Q2
Sell
-130
Closed -$28K 750
2024
Q1
$28K Buy
+130
New +$27.3K ﹤0.01% 436

Other funds holding CME

Salomon & Ludwin's CME Position: Q2 2026 in Review

Salomon & Ludwin reduced its CME Group (CME) stake by 46% in Q2 2026, selling an estimated $24.3K and leaving 104 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

Salomon & Ludwin first reported a position in CME in Q1 2024 and has held it in 6 quarters since. The position peaked at $58.6K in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Salomon & Ludwin held 104 shares of CME Group worth $24K as of Q2 2026.
  • Salomon & Ludwin sold 88 CME Group shares in Q2 2026, an estimated $24.3K.
  • CME Group made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1005 holding.
  • Salomon & Ludwin first reported a position in CME Group in Q1 2024 and has held it in 6 quarters since.
  • Salomon & Ludwin's CME Group position peaked at $58.6K in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.